Ulcerative colitis: open trials in Romania

18 open trials have a site in Romania. Registry data; only the trial team decides who can take part.

2023-507853-13-00
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Eli Lilly & Co.
Spitalul Universitar de Urgență București, Bucharest · Monza-Ares S.R.L., Bucharest · Spitalul Clinic Colentina Bucuresti, Bucharest · Spitalul Universitar de Urgenta Militar Central 'Dr. Carol Davila', Bucharest · Institutul Regional De Gastroenterologie Hepatologie Prof. Dr. Octavian Fodor Cluj, Cluj-Napoca · Valahia Medical S.R.L., Ploiesti · Centrul De Gastroenterologie Dr. Goldis S.R.L, Timișoara
Registry updated 2026-11-05
NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Trial Treatment · Phase 3 · Eli Lilly and Company
Spitalul Județean de Urgență Bacău, Bacau · Spitalul Universitar de Urgență București, Bucharest · Spitalul Clinic Colentina, Bucharest · Constanta County Emergency Clinical Hospital Sf.Ap.Andrei, Constanța · Spitalul Clinic Județean de Urgență, Craiova · S.C Centrul de Gastroenterologie Dr. Goldis S.R.L, Timișoara
Registry updated 2026-11-04
NCT07186101
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Trial Treatment · Phase 2 · Eli Lilly and Company
Spitalul Clinic Colentina, Bucharest · Delta Health Care, Bucharest · Constanta County Emergency Clinical Hospital Sf.Ap.Andrei, Constanța · Spital Judetean de Urgenta, Satu Mare · S.C Centrul de Gastroenterologie Dr. Goldis S.R.L, Timișoara
Registry updated 2026-11-04
NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Institutul Clinic Fundeni, Bucharest · Dermastyle S.R.L., Bucharest · Spitalul Clinic Colentina Bucuresti, Bucharest · Gastro Med S R L, Cluj-Napoca · Spitalul Clinic Judetean De Urgenta Sf. Spiridon Iasi, Jassi · Asociatia Oncohelp, Timișoara
Registry updated 2026-11-03
NCT07652294
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Delta Health Care S.R.L, Bucharest · Dermastyle S.R.L., Bucharest · Spitalul Clinic Colentina Bucuresti, Bucharest · Centrul Medical Sfanta Vineri S.R.L., Bucharest · Tvm Med Serv S.R.L., Cluj-Napoca · Gastromed S R L, Constanța · Asociatia Oncohelp, Timișoara
Registry updated 2026-11-03
NCT06619990
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Trial Treatment · Phase 1/2 · Xencor, Inc.
Bragadiru · Bucharest · Cluj-Napoca · Ploieşti · Timișoara
Registry updated 2026-10-30
NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Delta Health Care S.R.L, Bucharest · Centrul Medical Sfanta Vineri S.R.L., Bucharest · Dermastyle S.R.L., Bucharest · Memorial Healthcare International S R L, Bucharest · Spitalul Clinic Colentina Bucuresti, Bucharest · Tvm Med Serv S.R.L., Cluj-Napoca · Gastromed S R L, Constanța · Asociatia Oncohelp, Timișoara
Registry updated 2026-10-27
2024-511458-32-00
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
Trial Treatment · Phase 3 · Alfasigma S.p.A.
Dr. Victor Gomoiu Clinical Children Hospital, Bucharest · Spitalul Clinic de Urgenta pentru Copii Louis Turcanu Timisoara, Timișoara
Registry updated 2026-10-26
NCT07845487
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Palisade Bio
Site RO-001, Bucharest · Site RO-003, Bucharest · Site RO-006, Constanța · Site RO-004, Ploieşti · Site RO-005, Timișoara · Site RO-002, Timișoara
Registry updated 2026-10-21
NCT06865417
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Trial Treatment · Phase 3 · Alfasigma S.p.A.
Dr. Victor Gomoiu Clinical Children Hospital, Bucharest · Spitalul Clinic de Urgenta pentru Copii Louis Turcanu Timisoara, Timișoara
Registry updated 2026-10-20
2026-525798-38-00
An open label, balanced, randomized, two-treatment, four-period, two-sequence, single-dose, crossover fully replicate bioequivalence study comparing Mesalamine delayed release capsules 400 mg manufactured by Sun Pharmaceutical Industries Limited, India with Mesalamine Delayed-Release Capsules 400 mg, manufactured for Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, in healthy, adult, human subjects under fasting condition.
Trial Treatment · Phase 1 · Sun Pharmaceutical Industries Limited
Terapia S.A., Cluj-Napoca
Registry updated 2026-10-12
2026-525799-25-00
An open label, balanced, randomized, two-treatment, four-period, two-sequence, single-dose, crossover fully replicate bioequivalence study comparing Mesalamine delayed release capsules 400 mg, manufactured by Sun Pharmaceutical Industries Limited, India with Mesalamine Delayed-Release Capsules 400 mg, manufactured for Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, in healthy, adult, human subjects under fed condition.
Trial Treatment · Phase 1 · Sun Pharmaceutical Industries Limited
Terapia S.A., Cluj-Napoca
Registry updated 2026-10-12
NCT06405087
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Dr. Victor Gomoiu Clinical Children Hospital, Bucharest · Spitalul Clinic de Urgenta Pentru Copii ,,Grigore Alexandrescu,, Bucharest · Spitalul Clinic Judetean De Urgenta Pius Brinzeu Timisoara, Timisoara
Registry updated 2026-10-09
2025-522338-30-00
LY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study
Trial Treatment · Phase 2 · Eli Lilly & Co.
Delta Health Care S.R.L, Bucharest · Spitalul Clinic Colentina Bucuresti, Bucharest · Spitalul Clinic Judetean De Urgenta Sfantul Apostol Andrei Constanta, Constanța · Spital Judetean De Urgenta Satu Mare, Satu Mare · Centrul De Gastroenterologie Dr. Goldis S.R.L, Timișoara
Registry updated 2026-10-07
NCT06100289
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Trial Treatment · Phase 3 · Takeda
Spitalul Clinic de Urgenta Pentru Copii ,,Grigore Alexandrescu,, Bucharest · Dr. Victor Gomoiu Clinical Children Hospital, Bucharest · Spitalul Clinic Judetean De Urgenta Pius Brinzeu Timisoara, Timisoara
Registry updated 2026-08-03
NCT06764615
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Trial Treatment · Phase 2 · Takeda
Spitalul Clinic Colentina Bucuresti, Bucharest · Delta Health Care S.R.L, Bucharest · Institutul Clinic Fundeni, Bucharest · Memorial Healthcare International S R L, Bucharest · Monza-Ares S.R.L., Bucharest · Spitalul Clinic Dr. I. Cantacuzino, Bucharest · Cabinet Particular Policlinic Algomed S.R.L., Timisoara
Registry updated 2026-05-22
2025-522106-20-00
A double blinded, balanced, randomized, two-treatment, four-period, two-sequence, single-dose, crossover fully replicate bioequivalence study comparing Mesalamine Delayed Release Tablets USP 1.2 g manufactured by Sun Pharmaceutical Industries Limited, India with Mezavant (mesalamine) Delayed and Extended-Release Tablets 1.2 g product of Takeda Canada Inc., in healthy, adult, human subjects under fasting condition.
Trial Treatment · Phase 1 · Sun Pharmaceutical Industries Limited
Terapia S.A., Cluj-Napoca
Registry updated 2025-09-01
2025-521598-16-00
A double blinded, balanced, randomized, two-treatment, four-period, two-sequence, single-dose, crossover fully replicate bioequivalence study comparing Mesalamine Delayed Release Tablets USP 1.2 g manufactured by Sun Pharmaceutical Industries Limited, India with Mezavant (mesalamine) Delayed and Extended-Release Tablets 1.2 g product of Takeda Canada Inc., in healthy, adult, human subjects under fed condition.
Trial Treatment · Phase 1 · Sun Pharmaceutical Industries Limited
Terapia S.A., Cluj-Napoca
Registry updated 2025-07-22

All Ulcerative colitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error